CCCC- C4 Therapeutics, Inc.

Name: C4 Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

C4 Therapeutics, Inc. (CCCC) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. CCCC is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Adams Kendra	165.1K	$685.2K	-
Other	Reyno Leonard	156.4K	$649.0K	-
Dir	Anderson Kenneth Carl	146.5K	$608.1K	-
Other	Mahaney Paige	105.0K	$435.8K	-
Dir	Grogan Donna Roy	66.1K	$274.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 24, 2021	Prokupets Elena90	Director	Sell	32,743	$50.28	$1,646,251.50	-1.5%	-32.1%	-82.6%
Sep 21, 2021	Prokupets Elena90	Director	Sell	21,161	$50.09	$1,059,956.20	-1.8%	-37.1%	-82.2%
Sep 17, 2021	Salter Malcolm83	Director	Sell	755	$49.89	$37,666.95	-5.5%	-38.9%	-80.3%
Sep 16, 2021	Prokupets Elena90	Director	Sell	81,676	$48.78	$3,984,396.03	-3.3%	-38.4%	-80.2%
Sep 13, 2021	Prokupets Elena90	Director	Sell	9,210	$50.05	$460,984.74	-0.7%	-34.8%	-76.6%
Sep 10, 2021	Siegel Jolie	Chief Legal Officer	Sale+OE	12,500	$50.00	$625,000.00	-100%	-26.5%	-77.1%
Aug 20, 2021	Salter Malcolm83	Director	Sell	755	$40.73	$30,751.15	-5.2%	-1.5%	-72.4%
Aug 3, 2021	Fisher Stewart63	Chief Scientific Officer	Sell	17,057	$45.01	$767,812.33	-42.9%	+0.1%	-76.2%
Aug 3, 2021	Prokupets Elena90	Director	Sell	14,407	$45.16	$650,586.98	-14.0%	+0.1%	-76.2%
Aug 2, 2021	Prokupets Elena90	Director	Sell	15,593	$45.01	$701,773.90	-6.9%	+2.6%	-77.6%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC